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ABSTRACTS1359: ADHERENCE TO MASSIVE TRANSFUSION PROTOCOL IN MAJOR
VASCULAR SURGERY
Reza Arsalani Zadeh, Marion Wood, John Abraham. University Hospital
Morecambe Bay, Lancaster, UK.
Introduction: Emergency vascular surgery often requires massive trans-
fusion. Haemostatic transfusion protocols have shown to decrease mor-
tality in trauma. Similar approach may be necessary in vascular surgery.
Aims / Methods: The aim of this audit was to assess the adherence to local
massive transfusion protocols in vascular surgery. All patient undergoing
any form of vascular surgery requiring massive transfusion (>6 units) in
2011 were included in this audit.
Results: Total of 20 patients required massive transfusion.(age: 74.9 
8.1yrs, M:F¼15: 5).
Median time from receiving sample to issue of RBC, usage of RBC and to
issue of FFP were 00:55, 1:32 and 1:40min respectively.
A total of 185 RBC were used. (median 8(4-32)). A total equivalent of 94
units were used with cell salvage (median 2(2-21)).
A total of 117 FFP(median 4) and 23 units of platelet(median 2) were used.
Total wastage was 14 FFPs and 3 platelets.
Mean RBC: plasma ratio was 1.57. A post transfusion platelet count of>100
was achieved in only two patients.
Conclusion: Timing of availability of blood products and RBC:plasma
transfusion ratio was acceptable. However, pre-emptive use of platelet
should be encouraged. Increase awareness of all heath staff about the
presence of transfusion protocols is necessary.
1368: ASIT-ROULEAUX CLUB PRIZE WINNER: FASCIAL SHEATH CLOSURE
FOLLOWING PERCUTANEOUS ENDOVASCULAR ANEURYSM REPAIR:
CURRENT EVIDENCE FOR PRACTICE
Sophie Howell 2, Kirtan Patel 1, Vamsee Bhrugubanda 1, Andrew Choong 2.
1 Imperial College School of Medicine, London, UK; 2Outer North West London
Regional Vascular Unit, Northwick Park Hospital, London, UK.
Purpose: Fascial sheath closure(FSC) is an alternative to closure devices for
artery closure following percutaneous endovascular aneurysm repair(PE-
VAR). We present a systematic review and pooled data synthesis of FSC
following PEVAR.
Methods: Review methods were according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis(PRISMA) guidelines.
Published literature from ﬁve electronic databases was searched. Studied
outcomes included pathology treated, number of attempted fascial sheath
closures, primary technical success for closure, re-intervention rates and
causes, length of follow up
Results: 4 studies representing 315 patients were eligible for analysis. The
mean patient age was 64.5 with a male to female ratio of 6:1. 75.5% of
patients had FSC for PEVAR. The remainder had FSC for a percutaneous
endovascular treatment of fenestrated, thoracic, dissection or iliac pa-
thologies. 441 fascial sheath closures were attempted. Primary success was
89.8%. The most common complications requiring intervention within 24
hours were bleeding(6.8%) and thrombosis(2.5%). The majority of late
complications were managed conservatively(3.9%).
Conclusion: Fascial sheath closure has good primary technical success and
is associated with a low re-intervention rate. In these times of austerity,
perhaps this should be considered as a good alternative to the use of more
expensive closure devices in PEVAR.
1384: OMNIFLOW BIOSYNTHETIC GRAFTS: CURRENT EVIDENCE FOR
USE IN HAEMODIALYSIS
Vamsee Bhrugubanda 2, Sophie Howell 1, Kirtan Patel 2, Andrew Choong 1.
1Outer North West London Regional Vascular Unit, Northwick Park Hospital,
Middlesex, UK; 2 Imperial College School of Medicine, London, UK.
Background: Omniﬂow is a biosynthetic vascular prosthesis and is indi-
cated when a primary arterio-venous ﬁstula cannot be created. We present
a systematic review on its use in access for haemodialysis.
Methods: Review methods were according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis(PRISMA) guidelines.
Literature from ﬁve electronic databases was searched. Studied outcomes
included graft type created, time on dialysis, co-morbidities, primary and
secondary patency, rescue procedures for thrombosis and time to ﬁrst
puncture.Results: 3 studies were identiﬁed with 112 patients eligible for analysis.
This encompassed 128 procedures from 1992-2008. The mean age was
64.3. 56.3% of patients had a forearm loop ﬁstula, 23.4% forearm straight
ﬁstula and 20.3% thigh loop ﬁstula. 49.2% required rescue procedures for
thrombosis. Graft infection rate was 1.6%. There was no limb loss and only
10.9% demonstrated post-implantation stenoses. Primary patency was 63%
and 46.3% at 12 and 24 months respectively.
Conclusions: In patients where a primary arterio-venous ﬁstula cannot be
created, Omniﬂow represents a viable alternative to other prosthetics and
may confer beneﬁt as a biosynthetic prosthesis particularly in terms of
infection resistance. This represents the available data on Omniﬂow but
does not include improvements(Omniﬂow II), which may demonstrate
improved results.
1429: LONG-TERM CLINICAL OUTCOMES FOLLOWING LOWER LIMB
ARTERIAL ANGIOPLASTY
James Glasbey 3, Gareth Morris-Stiff 1, David Bosanquet 1,
Medhat Moawad 1, Gareth Davies 2, Eryl Hicks 2, Colin Davies 2,
Michael Lewis 1. 1Department of Surgery, Royal Glamorgan Hospital,
Ynysmaerdy, Llantristant, UK; 2Department of Radiology, Royal Glamorgan
Hospital, Ynysmaerdy, Llantristant, UK; 3Cardiff University School of Medicine,
Cardiff, UK.
Aim: This study aimed to determine clinical outcomes following lower
limb arterial angioplasty in a busy district general hospital practice.
Methods: All angioplasties performed over a 5 year period were identiﬁed.
Data collected included cardiovascular risk factors, indications for and
complications of angioplasty, limb salvage and patient survival rates, and
clinically signiﬁcant re-stenoses.
Results: 471 interventions were performed in 385 patients (231 men, 154
women). The median age was 67.9 years (range: 39-93 years). Indications
for angioplasty were critical ischemia (n¼247, 52%) and lifestyle-limiting
intermittent claudication (n¼224, 48%). Stenotic lesions accounted for 378
(80%) cases and occlusion for 93 (20%). Radiological success was obtained
in 417 (88.5%). Complications were observed in 42/471 (9.1%) of in-
terventions. The actual patient survival at 1, 2, and 3 years was 87.4%,
85.1% and 83.2% respectively. Indication for angioplasty and the number of
lesions present were identiﬁed as risk factors for outcome upon multi-
variate analysis. The cumulative post-angioplasty patency rates at 1, 2 and
3 years were 86.0%, 83.1% and 81.6% respectively.
Conclusions: Angioplasty for lower limb peripheral vascular disease can
be performed safely and efﬁcaciously. The patient survival and post-an-
gioplasty patency data reﬂect the progressive and multi-site nature of the
underlying disease process.
1472: ROUTINE SURGICAL OUTPATIENT FOLLOW-UP ONE YEAR AFTER
CAROTID ENDARTERECTOMY DOES NOT RESULT IN MEDICAL OR SURGI-
CAL REINTERVENTION
Shiraz Sabah 1, Ryan Geleit 2, Sandip Sarkar 1, Constantinos Kyriakides 1.
1Royal London Hospital, London, UK; 2 Barts and the London School of
Medicine and Dentistry, London, UK.
Aim: There is considerable variation in post carotid endarterectomy
follow-up complicated by the paucity of evidence for subsequent man-
agement. We assessed whether postoperative follow-up in the ﬁrst year
resulted in any management intervention.
Method: A retrospective review of all patients having carotid endarter-
ectomy in our institution between November 2009 and December 2011
was carried out. Case notes were reviewed for follow-up and further
management in the subsequent 12 months.
Results: 101 unilateral cases were performed, of which 56 were
requested for follow up after discharge. Of the 51 patients who atten-
ded, 28 underwent further duplex surveillance. 2 patients were found
to have asymptomatic ipsilateral occlusion. 1 patient had re-stenosed
to the same level as their pre-surgical scan - 70-79% (NASCET). 7 pa-
tients had minor stenosis and 18 were free of any stenosis. Of those
under duplex surveillance, 4 patients had progression of their known
contralateral stenosis. No patients had further active medical or sur-
gical intervention.
Conclusions: Surveillance of asymptomatic carotid stenosis even in the
context of previous carotid endarterectomy does not result in reinter-
vention within the ﬁrst year. Educating patients about carotid artery
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ABSTRACTSterritory symptoms and the importance of urgent presentation may be
more beneﬁcial than routine follow up
1478: REVIEW OF OUTCOMES OF AV GRAFTS FOR HAEMODIALYSIS e A
CLINICAL AUDIT
Christodoulos Neophytou, Matthew Gale, Keith Rigg. Nottingham City
Hospital, Nottingham, UK.
Aims: The aim of this audit is to assess the outcomes of AV grafts for
haemodialysis at Nottingham City Hospital.
Methods: The records of patients that underwent procedures related to AV
grafts for haemodialysis (insertion or revision/removal) were retrospec-
tively reviewed. The period covered was between January 2005 and
June 2012.Results:Within a period of 8½ years, a total of 112 procedures took place.
71 patients received a total of 78 AV grafts (combination of brachial, radial,
axillary and femoral vessels were used). Furthermore, 44 revisions
occurred, including 14 angioplasties (due to stenosis), 8 removals of graft
(due to bleeding or infection) and 6 thrombectomies. Most patients were
followed-up for at least one year. Overall out of 9 recorded graft infections
3 were related to upper limb grafts and 6 to lower limb grafts. 8 were
treated surgically with removal of the graft and 1 conservatively with
antibiotics. 7 deaths happened but none was a direct complication of AV
graft insertion or revision.
Conclusions: Arteriovenous grafts created for dialysis have many associ-
ated complications, the main being patency and infection. Our ﬁndings
show less infection rates compared to the literature but same proportion of
site of infection (2:1 lower to upper limb).
